Cognition Therapeutics, Inc. · NASDAQ:CGTX

Caggiano Anthony bought 10,000 Cognition Therapeutics, Inc. shares (Form 4)

Traded Apr 16, 2026 · Filed Apr 20, 2026

On Apr 16, 2026, Caggiano Anthony (Chief Medical Officer) bought 10,000 Cognition Therapeutics, Inc. shares at US$1.11 for US$11,100, leaving 874,906 shares. Filed Apr 20, 2026 (Form 4).

Bought
10,000 shares
Price
US$1.11
Value
US$11,100
Holding after
874,906 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 16, 2026Common StockBuy10,000US$1.11874,906Direct

Source

View original at SEC

Related